Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aminotransferase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111748590B reveals enzymatic synthesis for Sacubitril intermediates. Offers cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN103194501B reveals enzymatic synthesis for high purity chiral amino acids. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN119614533B reveals thermostable enzyme mutants improving R-chiral amine synthesis efficiency and supply chain stability for pharmaceutical intermediates.
Novel aminotransferase mutant enables 99% ee sitagliptin intermediate. Robust DMSO tolerance ensures cost reduction in pharma manufacturing.
Patent CN116179503A details a novel recombinant aminotransferase route for Niraparib intermediates, offering high stereoselectivity and eliminating costly chiral chromatography for supply chain efficiency.
Novel aminotransferase mutants enable high-yield sitagliptin synthesis. Cost-effective, scalable pharma intermediate solution with >99% ee.
Patent CN107384887A reveals high-purity Sitagliptin synthesis via aminotransferase. Achieves 99% ee and 76% yield, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel omega-aminotransferase mutant enables high-yield sitagliptin intermediate production with 99% ee value and reduced solvent constraints for global supply chains.